INT177643

From wiki-pain
Revision as of 16:07, 20 September 2012 by Daniel (Talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Context Info
Confidence 0.36
First Reported 2004
Last Reported 2010
Negated 1
Speculated 0
Reported most in Body
Documents 12
Total Number 12
Disease Relevance 8.59
Pain Relevance 0.22

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cytosol (CENPJ) cytoskeleton (CENPJ) cell division (CENPJ)
cytoplasm (CENPJ)
Anatomy Link Frequency
nasal 3
muscle 1
CENPJ (Homo sapiens)
Pain Link Frequency Relevance Heat
depression 66 100.00 Very High Very High Very High
alcohol 23 83.56 Quite High
antagonist 7 61.36 Quite High
Inflammation 9 54.44 Quite High
corticosteroid 2 52.56 Quite High
Angina 8 41.04 Quite Low
Neurobehavioral 6 16.52 Low Low
Serotonin 18 5.00 Very Low Very Low Very Low
cva 9 5.00 Very Low Very Low Very Low
antidepressant 5 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Depression 100 100.00 Very High Very High Very High
Obesity 58 99.44 Very High Very High Very High
Central Sleep Apnea 160 99.42 Very High Very High Very High
Airway Obstruction 16 99.36 Very High Very High Very High
Apnoea 428 98.96 Very High Very High Very High
Myocardial Infarction 44 98.94 Very High Very High Very High
Weight Loss 16 94.88 High High
Recurrence 6 94.48 High High
Cardiovascular Disease 42 92.40 High High
Congenital Anomalies 8 91.76 High High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
It should be recognized that armodafinil does not treat the underlying airway obstruction and should not be considered a replacement for nCPAP therapy in patients with OSA.
CPAP Binding (replacement) of associated with apnoea and airway obstruction
1) Confidence 0.36 Published 2007 Journal Sleep Breath Section Body Doc Link PMC2194800 Disease Relevance 0.80 Pain Relevance 0
The study enrolled 258 patients who had heart failure and central sleep apnea; participants were randomly assigned to the nasal CPAP treatment group (n = 128) or no CPAP (130 patients).
CPAP Binding (assigned) of in nasal associated with central sleep apnea and myocardial infarction
2) Confidence 0.27 Published 2008 Journal Heart Fail Rev Section Body Doc Link PMC2698052 Disease Relevance 0.96 Pain Relevance 0
The study enrolled 258 patients who had heart failure and central sleep apnea; participants were randomly assigned to the nasal CPAP treatment group (n = 128) or no CPAP (130 patients).
CPAP Binding (assigned) of in nasal associated with central sleep apnea and myocardial infarction
3) Confidence 0.27 Published 2008 Journal Heart Fail Rev Section Body Doc Link PMC2698052 Disease Relevance 0.95 Pain Relevance 0
The independent variables influencing continued use of CPAP were CPAP usage at 3 months (with a relative risk [RR] of stopping CPAP of 13.8 comparing <2 hours vs ?
CPAP Binding (usage) of
4) Confidence 0.19 Published 2006 Journal Neuropsychiatric Disease and Treatment Section Body Doc Link PMC2671821 Disease Relevance 0.29 Pain Relevance 0
The independent variables influencing continued use of CPAP were CPAP usage at 3 months (with a relative risk [RR] of stopping CPAP of 13.8 comparing <2 hours vs ?
CPAP Binding (use) of
5) Confidence 0.19 Published 2006 Journal Neuropsychiatric Disease and Treatment Section Body Doc Link PMC2671821 Disease Relevance 0.28 Pain Relevance 0
Alternatively, through expiratory muscle recruitment, CPAP or EPAP may also protect or even decrease EELV [13,26].
CPAP Binding (recruitment) of in muscle
6) Confidence 0.07 Published 2004 Journal Crit Care Section Body Doc Link PMC420031 Disease Relevance 0.17 Pain Relevance 0
Patients were considered to be CPAP compliant if they used CPAP an average ?
CPAP Binding (average) of
7) Confidence 0.07 Published 2006 Journal Respir Res Section Body Doc Link PMC1373626 Disease Relevance 0.54 Pain Relevance 0
They compared the cardiovascular outcomes of those patients who were intolerant of CPAP (untreated group, 61 patients) with those continuing CPAP therapy (107 patients).
CPAP Binding (intolerant) of
8) Confidence 0.07 Published 2006 Journal Respir Res Section Body Doc Link PMC1373626 Disease Relevance 1.03 Pain Relevance 0
Routine troubleshooting took place in an effort to maximize compliance with nasal CPAP.
CPAP Binding (compliance) of in nasal
9) Confidence 0.07 Published 2006 Journal Respir Res Section Body Doc Link PMC1373626 Disease Relevance 0.55 Pain Relevance 0
Compliance of CPAP
CPAP Binding (Compliance) of
10) Confidence 0.07 Published 2006 Journal Respir Res Section Body Doc Link PMC1373626 Disease Relevance 0.74 Pain Relevance 0.04
However, Lewis et al. [37] did not find any association between baseline depression scores and subsequent CPAP use for the first month of treatment.
CPAP Neg (not) Binding (association) of associated with depression
11) Confidence 0.03 Published 2005 Journal Ann Gen Psychiatry Section Body Doc Link PMC1181621 Disease Relevance 0.64 Pain Relevance 0.10
Postoperative PSG and CPAP are frequently recommended after T&A in obese children.
CPAP Binding (recommended) of associated with obesity
12) Confidence 0.03 Published 2010 Journal Korean Journal of Pediatrics Section Body Doc Link PMC3004500 Disease Relevance 1.63 Pain Relevance 0.08

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox